Status:
COMPLETED
Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients
Lead Sponsor:
Novartis
Conditions:
Liver Transplant
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether the switch from tacrolimus to cyclosporine microemulsion benefits post-transplant diabetes management (in terms of glycogenic control and insulin dosa...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- At least 4 months post-transplant
- Patients in treatment with tacrolimus
- Post-transplant diabetes treated with insulin for at least one month
- Exclusion Criteria
- Known hypersensitivity to cyclosporine microemulsion
- Investigational drug within 60 days before baseline or during the study
- Patients who cannot comply with the study requirements
- Other protocol-defined exclusion criteria applied
Exclusion
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT00171743
Start Date
April 1 2004
End Date
January 1 2006
Last Update
June 7 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.